Illumina, Inc. vs Peloton Interactive Inc — how do they compare? Illumina, Inc. trades at $189.78 (market cap $27.94B), while Peloton Interactive Inc trades at $6.43 (market cap $2.82B). The key difference: Illumina, Inc. is far larger — about 9.9× Peloton Interactive Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | PTON | |
|---|---|---|
Market Cap | $27.94B | $2.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $194.33 | $9.00 |
52-Week Low | $91.00 | $3.71 |
Enterprise Value | $29.33B | $3.42B |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Peloton (PTON) trades at $6.545, up 6.94% today, showing stabilization after years of decline. The company achieved positive operating cash flow of $333M in 2025 and is projected to return to net profitability in 2026. Technical indicators are bullish on moving averages, while fundamentals reveal high debt levels but improving margins. Recent news highlights leadership changes and inclusion in the S&P SmallCap 600 index as potential catalysts.
Outlook remains cautious but improving; PTON offers turnaround potential with cost controls driving cash flow, but risks include persistent revenue declines and substantial long-term debt of $1.49B. Analyst consensus is mixed with a $7.50 price target, suggesting modest upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →